fbpx
0
Pain Therapy, Carolina Pain Scrambler Center, Greenville South Carolina

Scrambler Therapy For Chemotherapy Neuropathy

Clinical Trial
Support Care Cancer
. 2020 Mar;28(3):1183-1197. doi: 10.1007/s00520-019-04881-3. Epub 2019 Jun 17.
Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial
Charles Loprinzi 1 , Jennifer G Le-Rademacher 2 , Neil Majithia 2 , Ryan P McMurray 2 , Carrie R O’Neill 2 , Markus A Bendel 2 , Andreas Beutler 2 , Daniel H Lachance 2 , Andrea Cheville 2 , David M Strick 2 , David F Black 2 , Jon C Tilburt 2 , Thomas J Smith 2
Affiliations Expand
PMID: 31209630 DOI: 10.1007/s00520-019-04881-3
Abstract
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a prominent clinical problem, with limited effective therapies. Preliminary non-randomized clinical trial data support that Scrambler Therapy is helpful in this situation.
Methods: Patients were eligible if they had CIPN symptoms for at least 3 months and CIPN-related tingling or pain at least 4/10 in severity during the week prior to registration. They were randomized to receive Scrambler Therapy versus transcutaneous electrical nerve stimulation (TENS) for 2 weeks. Patient-reported outcomes (PROs) were utilized to measure efficacy and toxicity daily for 2 weeks during therapy and then weekly for 8 additional weeks.
Results: This study accrued 50 patients, 25 to each of the 2 study arms; 46 patients were evaluable. There were twice as many Scrambler-treated patients who had at least a 50% documented improvement during the 2 treatment weeks, from their baseline pain, tingling, and numbness scores, when compared with the TENS-treated patients (from 36 to 56% compared with 16-28% for each symptom). Global Impression of Change scores for “neuropathy symptoms,” pain, and quality of life were similarly improved during the treatment weeks. Patients in the Scrambler group were more likely than those in the TENS group to recommend their treatment to other patients, during both the 2-week treatment period and the 8-week follow-up period (p < 0.0001). Minimal toxicity was observed.
Conclusions: The results from this pilot trial were positive, supporting the conduct of further investigations regarding the use of Scrambler Therapy for treating CIPN.
Keywords: Chemotherapy-induced peripheral neuropathy; Scrambler; TENS.

Article Provided By: pubmed
Carolina Pain Scrambler Logo, Chronic Pain, Greenville, SCIf you would like to discuss what Carolina Pain Scrambler do to help relieve your chronic pain symptoms or receive more information on our treatment process, please do not hesitate to call us at 864-520-5011 or you can email us at info@carolinapainscrambler.com

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *